ABC Money
Home

NYT staffer won't appear in Zyprexa case


Published :
Tue, 06 Feb 2007 19:46
By : Agencies
Print this Story


AddThis Social Bookmark Button

NEW YORK (AFX) - The New York Times on Tuesday declined a request from a federal judge to have one of its reporters appear in court to discuss how he obtained confidential documents related to the anti-psychotic drug Zyprexa.

In a letter to Jack B. Weinstein, a judge in U.S. District Court for the Eastern District of New York, New York Times attorney George Freeman said that as a matter of 'long-held principle,' the company believed it would be 'inappropriate' to discuss how its reporters gather news or how editorial judgments are made at the newspaper.

Last week Weinstein had requested that the reporter, Alex Berenson, appear in court on Wednesday to discuss testimony that the judge said had implicated the writer in a 'conspiracy' to obtain the documents, which had been placed under seal by the court.

'We guard quite zealously our role as a member of a free and independent press and believe quite passionately that, consistent with the principles embodied in the First Amendment, it is not the role of the newspaper or its reporters to submit to cross-examination about such matters even where it may otherwise serve our particular interests in a particular case to do so,' Freeman wrote.

Berenson wrote a number of articles beginning late last year saying that Indianapolis-based Eli Lilly and Co., which makes the drug, had downplayed its risks and marketed it for unapproved uses. Lilly has denied the charges.

Weinstein wrote in a court filing last week that he was requesting Berenson to appear voluntarily after hearing testimony from James Gottstein, an Alaska-based lawyer named in Berenson's stories as the source of the documents.

Gottstein had testified that Berenson told him that a plaintiff's expert named Dr. David Egilman had a number of documents that Gottstein could obtain by subpoena.

Copyright 2006 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.




Share on


 You Might Like
Eli Lilly was concerned about Zyprexa side effects from 1998 - report
Judge asks N.Y. Times reporter to appear
+
Brits can hang on to their BlackBerrys
High court to review 'lights' case

Comment on this Article
Comment:
Title:
Name:
Please Enter
 
Here
  

 Search News

 Look For
Business
Credit cards
Finance
Loans
Money
Mortgages

 
 Stock Quotes *
SYMBOL
LAST
CHANGE
DOW JONES
8742.46
-27.24 ( -0.31 %)
NASDAQ
1617.01
+17.95 ( 1.13 %)
FTSE 100
4505.37
-2.14 ( -0.05 %)

SYMBOL ( 2009-01-08 )
LAST
CHANGE
RECKITT BENCKISER ( 11:35am )
2760.00
+80.00 ( 2.99 %)
IMPERIAL TOBACCO ( 11:35am )
1868.00
+48.00 ( 2.64 %)
ROYAL DUTCH SHELL ( 11:35am )
1841.00
+36.00 ( 2.01 %)
BRITISH AMERICAN TOBACCO ( 11:35am )
1786.00
+32.00 ( 1.84 %)
ROYAL DUTCH SHELL-B ( 11:35am )
1768.00
+32.00 ( 1.86 %)

SYMBOL ( 2009-01-08 )
LAST
CHANGE
EXXON MOBIL CORP ( 4:01pm )
79.09
+0.84 ( 1.08 %)
MICROSOFT ( 4:00pm )
20.12
+0.61 ( 3.10 %)
3M COMPANY ( 4:01pm )
58.58
+0.51 ( 0.88 %)
VERIZON COMMUNICATIONS INC ( 4:00pm )
32.39
+0.49 ( 1.54 %)
ALCOA INC ( 4:00pm )
11.36
+0.47 ( 4.42 %)

SYMBOL ( 2009-01-08 )
LAST
CHANGE
SEARS HOLDINGS CORPORATION ( 4:00pm )
49.98
+9.43 ( 20.96 %)
AMER SCI ENGR ( 4:00pm )
79.65
+7.87 ( 10.77 %)
FIRST SOLAR INC ( 4:00pm )
155.36
+6.86 ( 4.68 %)
COMM BANCORP INC ( 9:30am )
39.48
+4.47 ( 11.32 %)
ISRAMCO INC ( 1:42pm )
31.25
+4.39 ( 14.49 %)

Gainers & Losers
Dow Jones
Euro Stoxx 50
FTSE 100
FTSE 250
FTSE AIM
FTSE ALL
Nasdaq

 Portfolio Manager

You must log in to access this area of the site. If you are not a registered user click here to sign up for instant access!


 Finance Explained

Money making ideas

Save money

Money management
Savings accounts
Investing money
Share dealing
Stock broker
Forex currency trading
Pension plans
Functions of Money

(c) 2007 ABCmoney.co.uk, All Rights Reserved
*ABCMoney.co.uk does not guarantee the accuracy of any share prices or stock quotations displayed. These are not real time quotes; all are delayed by at least twenty minutes and are for information purposes only.